Breaking News

You are here » Indian-Commodity  :  Corporate  :  Glenmark reports positive data in Phase 2a study of 'GBR 830'

01-Aug2017

Glenmark reports positive data in Phase 2a study of 'GBR 830'

Glenmark Pharmaceuticals has reported a positive data from a Phase 2a study of GBR 830, an investigational, anti-OX40 monoclonal antibody, in atopic dermatitis (AD), a common and serious chronic skin disease. The study evaluated the safety, biological and clinical activity, and pharmacokinetics of GBR 830, relative to placebo, in adults with moderate-to-severe AD with history of inadequate response to topical therapies.

Based on the results of this Phase 2a study, Glenmark is firmly committed to advancing GBR 830 for patients with AD and plans to initiate a Phase 2b trial in the first half of calendar year 2018. Glenmark is planning to submit these data for presentation at upcoming scientific meetings and publication in a peer-reviewed journal.

Glenmark Pharmaceuticals is a global innovative pharmaceutical company with operations in more than 50 countries. Glenmark has a diverse pipeline with several compounds in various stages of clinical development, primarily focused in the areas of oncology, respiratory disease, and dermatology.



Related News

View all news

Future Consumer raises funds worth Rs 50 crore via NCDs

Future Consumer has raised funds worth Rs 50 crore. The Committee of Directors of the Board of Directors of the company has on October 12, 2018, allotted 500 Senior, Secured, Non-Convertible Debentures......

Cupid bags order worth Rs 7.30 crore from UNFPA

Cupid has received an order worth Rs 7.30 crore from UNFPA to supply Male Condoms to Zambia. The order has to be executed over a period of four months. This is the single largest and the first big order......

Glenmark's arm receives USFDA's final approval for Hydrocortisone Valerate Cream

Glenmark Pharmaceuticals' subsidiary -- Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Hydrocortisone Valerate Cream USP,......

Top News

View all news

Ashiana Housing wins two awards

Ashiana Housing has won two awards. Realty Plus Awards 2018 has felicitated 'Ashiana Umang' as 'Best Themed Project' and the company's website as the 'Best Real Estate Website of the year'.Ashiana Umang......

Tata Power inaugurates second 'All-women' CRC in Mumbai

Tata Power has inaugurated its second 'All Women' Customer Relations Centre (CRC) in Borivali (East), Mumbai, with an aim to continue providing their talented and highly skilled women employees with new......

McLeod Russel hands over specified assets of eight Tea Estates to M K Shah Exports

McLeod Russel India has handed over the specified assets of the eight Tea Estates of the company to M K Shah Exports.Post completion of due diligence by M K Shah Exports (Buyer) and on compliance of the......